Photodynamic Therapy for the Treatment of Glioblastoma

Overview

Journal Front Surg

Specialty General Surgery

Date 2020 Feb 11

PMID 32039232

Citations 71

Authors

Samuel W Cramer

Clark C Chen

Affiliations

Soon will be listed here.

Abstract

Glioblastoma is the most common form of adult brain cancer and remains one of the deadliest of human cancers. The current standard-of-care involves maximal tumor resection followed by treatment with concurrent radiation therapy and the chemotherapy temozolomide. Recurrence after this therapy is nearly universal within 2 years of diagnosis. Notably, >80% of recurrence is found in the region adjacent to the resection cavity. The need for improved local control in this region, thus remains unmet. The FDA approval of 5-aminolevulinic acid (5-ALA) for fluorescence guided glioblastoma resection renewed interests in leveraging this agent as a means to administer photodynamic therapy (PDT). Here we review the general principles of PDT as well as the available literature on PDT as a glioblastoma therapeutic platform.

Citing Articles

Noninvasive Ultra Low Intensity Light Photodynamic Treatment of Glioblastoma with Drug Augmentation: LoGlo PDT Regimen.

Kast R, Kast A, Arnhold J, Capanni F, Milla Sanabria L, Bader N Brain Sci. 2025; 14(12.

PMID: 39766363 PMC: 11674893. DOI: 10.3390/brainsci14121164.

Advancements and challenges in brain cancer therapeutics.

Bai F, Deng Y, Li L, Lv M, Razzokov J, Xu Q Exploration (Beijing). 2024; 4(6):20230177.

PMID: 39713205 PMC: 11655316. DOI: 10.1002/EXP.20230177.

Viral-Porphyrin Combo: Photodynamic and Oncolytic Viral Therapy for Potent Glioblastoma Treatment.

Nazarenko A, Shkirdova A, Orlova E, Biryukova Y, Vorovitch M, Kolyasnikova N Int J Mol Sci. 2024; 25(23).

PMID: 39684289 PMC: 11640982. DOI: 10.3390/ijms252312578.

Expression and Clinical Significance of Lymphocyte Subpopulations and Peripheral Inflammatory Markers in Glioma.

Zhou C, Xu L, Geng M, Hu S J Inflamm Res. 2024; 17:9423-9451.

PMID: 39600678 PMC: 11590653. DOI: 10.2147/JIR.S474577.

Stereotactic Photodynamic Therapy of Recurrent Malignant Gliomas.

Rafaelian A, Martynov B, Chemodakova K, Kholyavin A, Martynov R, Klimenkova E Sovrem Tekhnologii Med. 2024; 16(2):58-65.

PMID: 39539750 PMC: 11556050. DOI: 10.17691/stm2024.16.2.06.

References

Origitano T, Karesh S, Henkin R, Halama J, Reichman O . Photodynamic therapy for intracranial neoplasms: investigations of photosensitizer uptake and distribution using indium-111 Photofrin-II single photon emission computed tomography scans in humans with intracranial neoplasms. Neurosurgery. 1993; 32(3):357-63; discussion 363-4. DOI: 10.1227/00006123-199303000-00004. View

Ewelt C, Nemes A, Senner V, Wolfer J, Brokinkel B, Stummer W . Fluorescence in neurosurgery: Its diagnostic and therapeutic use. Review of the literature. J Photochem Photobiol B. 2015; 148:302-309. DOI: 10.1016/j.jphotobiol.2015.05.002. View

Stylli S, Howes M, MacGregor L, Rajendra P, Kaye A . Photodynamic therapy of brain tumours: evaluation of porphyrin uptake versus clinical outcome. J Clin Neurosci. 2004; 11(6):584-96. DOI: 10.1016/j.jocn.2004.02.001. View

Johansson A, Faber F, Kniebuhler G, Stepp H, Sroka R, Egensperger R . Protoporphyrin IX fluorescence and photobleaching during interstitial photodynamic therapy of malignant gliomas for early treatment prognosis. Lasers Surg Med. 2013; 45(4):225-34. DOI: 10.1002/lsm.22126. View

Stepp H, Stummer W . 5-ALA in the management of malignant glioma. Lasers Surg Med. 2018; 50(5):399-419. DOI: 10.1002/lsm.22933. View

Maier P, Hartmann L, Wenz F, Herskind C . Cellular Pathways in Response to Ionizing Radiation and Their Targetability for Tumor Radiosensitization. Int J Mol Sci. 2016; 17(1). PMC: 4730344. DOI: 10.3390/ijms17010102. View

Ganau M . Tackling gliomas with nanoformulated antineoplastic drugs: suitability of hyaluronic acid nanoparticles. Clin Transl Oncol. 2013; 16(2):220-3. DOI: 10.1007/s12094-013-1114-1. View

Stylli S, Kaye A, MacGregor L, Howes M, Rajendra P . Photodynamic therapy of high grade glioma - long term survival. J Clin Neurosci. 2005; 12(4):389-98. DOI: 10.1016/j.jocn.2005.01.006. View

Muller P, Wilson B . Photodynamic therapy for recurrent supratentorial gliomas. Semin Surg Oncol. 1995; 11(5):346-54. DOI: 10.1002/ssu.2980110504. View

10.

Kawai N, Hirohashi Y, Ebihara Y, Saito T, Murai A, Saito T . ABCG2 expression is related to low 5-ALA photodynamic diagnosis (PDD) efficacy and cancer stem cell phenotype, and suppression of ABCG2 improves the efficacy of PDD. PLoS One. 2019; 14(5):e0216503. PMC: 6513434. DOI: 10.1371/journal.pone.0216503. View

11.

Dupont C, Vermandel M, Leroy H, Quidet M, Lecomte F, Delhem N . INtraoperative photoDYnamic Therapy for GliOblastomas (INDYGO): Study Protocol for a Phase I Clinical Trial. Neurosurgery. 2018; 84(6):E414-E419. DOI: 10.1093/neuros/nyy324. View

12.

Hirschberg H, Uzal F, Chighvinadze D, Zhang M, Peng Q, Madsen S . Disruption of the blood-brain barrier following ALA-mediated photodynamic therapy. Lasers Surg Med. 2008; 40(8):535-42. PMC: 2667623. DOI: 10.1002/lsm.20670. View

13.

Stupp R, Mason W, van den Bent M, Weller M, Fisher B, Taphoorn M . Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005; 352(10):987-96. DOI: 10.1056/NEJMoa043330. View

14.

Sahm F, Capper D, Jeibmann A, Habel A, Paulus W, Troost D . Addressing diffuse glioma as a systemic brain disease with single-cell analysis. Arch Neurol. 2011; 69(4):523-6. DOI: 10.1001/archneurol.2011.2910. View

15.

Ganau M, Ch Syrmos N, DArco F, Ganau L, Chibbaro S, Prisco L . Enhancing contrast agents and radiotracers performance through hyaluronic acid-coating in neuroradiology and nuclear medicine. Hell J Nucl Med. 2017; 20(2):166-168. DOI: 10.1967/s002449910558. View

16.

Vanaclocha V, Sureda M, Azinovic I, Rebollo J, Canon R, Saiz Sapena N . Photodynamic therapy in the treatment of brain tumours. A feasibility study. Photodiagnosis Photodyn Ther. 2015; 12(3):422-7. DOI: 10.1016/j.pdpdt.2015.05.007. View

17.

Tang X, Wu J, Lin B, Cui S, Liu H, Yu R . Near-infrared light-activated red-emitting upconverting nanoplatform for T-weighted magnetic resonance imaging and photodynamic therapy. Acta Biomater. 2018; 74:360-373. DOI: 10.1016/j.actbio.2018.05.017. View

18.

Mahmoudi K, Garvey K, Bouras A, Cramer G, Stepp H, Jesu Raj J . 5-aminolevulinic acid photodynamic therapy for the treatment of high-grade gliomas. J Neurooncol. 2019; 141(3):595-607. PMC: 6538286. DOI: 10.1007/s11060-019-03103-4. View

19.

Johansson A, Palte G, Schnell O, Tonn J, Herms J, Stepp H . 5-Aminolevulinic acid-induced protoporphyrin IX levels in tissue of human malignant brain tumors. Photochem Photobiol. 2010; 86(6):1373-8. DOI: 10.1111/j.1751-1097.2010.00799.x. View

20.

Hirschberg H, Berg K, Peng Q . Photodynamic therapy mediated immune therapy of brain tumors. Neuroimmunol Neuroinflamm. 2018; 5. PMC: 6138455. DOI: 10.20517/2347-8659.2018.31. View